logo
logo

Dynocardia announced it raised $675,000 in an initial filing from an offering of $2 Million

Mar 14, 20254 months ago

Amount Raised

$675,000

Round Type

seed

Newton CentreHealth Care

Company Information

Company

Dynocardia

Location

1188 CENTER STREET

Newton Centre, Massachusetts, United States

About

Dynocardia is a biomedical device development company committed to satisfying critical unmet needs to improve healthcare worldwide. ViTrack™, our lead diagnostic device, is powered our proprietary technology making it the only stand-alone, cuff-less device that allows for continuous, non-invasive blood pressure (cNIBP) measurement. Unlike conventional occlusive devices, ViTrack offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable, mobile, and easy to use, with the accuracy of intra-arterial lines. ViTrack, with data-rich capability that includes heart rate, heart rhythm, and respiratory parameters in addition to blood pressure, enables early intervention prior to acute events.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People